Vicor insider plans sale of 200 shares

Vicor insider Andrew Damico has filed a Form 144 indicating an intent to sell 200 shares of Vicor common stock.

Accepted by SEC EDGAR 01/15/2026 - 04:28 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Vicor insider Andrew Damico has filed a Form 144 indicating an intent to sell 200 shares of Vicor common stock. The planned sale, through Morgan Stanley Smith Barney on NASDAQ, has an aggregate market value of $29,064, with 32,925,914 Vicor shares outstanding. The 200 shares were acquired the same day via a cash exercise of stock options.

The notice also lists prior Rule 10b5-1 sales by Damico over the past three months, including 14,677 shares sold on 10/22/2025 for $1,211,253 and several smaller transactions. By signing the form, the insider represents that he is not aware of any undisclosed material adverse information about Vicor.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Vicor (VICR) insider Andrew Damico plan to sell under this Form 144?

The notice states that Andrew Damico plans to sell 200 shares of Vicor common stock through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $29,064.

How did the Vicor (VICR) insider acquire the 200 shares to be sold?

The filing shows the 200 Vicor common shares were acquired on 01/15/2026 via an exercise of stock options, paid in cash on the same date.

How many Vicor (VICR) shares are outstanding in this Form 144 disclosure?

The Form 144 indicates that 32,925,914 Vicor common shares are outstanding, providing context for the 200 shares planned for sale.

What recent Rule 10b5-1 sales by Andrew Damico are disclosed for Vicor (VICR)?

The document lists several Rule 10b5-1 sales, including 14,677 shares sold on 10/22/2025 for $1,211,253, along with multiple smaller transactions between 10/21/2025 and 01/05/2026.

What representation does the Vicor (VICR) insider make when signing Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about Vicor’s current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned Vicor (VICR) Form 144 sale?

The planned sale of 200 Vicor common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001830195
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VICOR CORPORATION
SEC File Number	000-18277
Address of Issuer	25 Frontage Road Andover MASSACHUSETTS 01810
Phone	9784702900
Name of Person for Whose Account the Securities are To Be Sold	ANDREW DAMICO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	200	29064.00	32925914	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Exercise of Stock Options	Issuer			200	01/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	01/05/2026	400	57000.00
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	12/19/2025	754	78416.00
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	11/17/2025	2000	175380.00
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	11/12/2025	1908	189145.88
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	10/24/2025	2071	196326.89
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	10/23/2025	565	50850.00
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	10/22/2025	14677	1211253.00
10b5-1 Sales for ANDREW DAMICO 25 Frontage Road Andover MA 01810	Common	10/21/2025	1000	68000.00

144: Remarks and Signature

Remarks
Date of Notice	01/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/12/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew D'Amico
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)